课题基金 / 基金详情

Improving Spontaneous Gradient Formation in Hydrogels Using Agent-Based Modeling

Improving Spontaneous Gradient Formation in Hydrogels Using Agent-Based Modeling
使用基于代理的建模改善水凝胶中的自发梯度形成
批准号:
10467985
负责人:
Lauren Pruett
金额:
$3.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2022-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目摘要 在这项提案中,我们的目标是设计一种生物材料支架,通过改进 基于我们发明的一种新的水凝胶生物材料,称为微孔退火颗粒(MAP) 凝胶。MAP凝胶由微米级球形积木组成,使用微流控生成和 原位退火,形成稳定的支架。MAP支架被证明可以促进皮肤和大脑的愈合 通过孔洞依赖减少伤口炎症和组织整合。我们专注于 材料的改进,以应对糖尿病创面材料治疗的已知困难; 血管生成减少。具体地说,我们已经开发出了肝素“微岛”,使其具有异质性。 分布在支架内,形成微梯度,促进血管生成。我们假设优化 “肝素微岛”的浓度和间距将改善血管生成和糖尿病伤口 结案了。 我们将使用体内和硅胶方法来评估和优化这些特性。目标1侧重于 不同浓度肝素微粒的合成及血管内皮细胞生长的定量研究 使用我们实验室开发的一种新的检测方法,由颗粒产生的因子(VEGF)梯度。相对的 梯度强度将被用来在MAP支架内产生基于试剂的血管生成模型 不同浓度和比例的肝素岛。目标2侧重于了解 应用MAP支架治疗的糖尿病创面的细胞分布和血管内皮生长因子浓度。另外, 使用实验输入来告知模型,我们将运行多个模拟来开发最优支架 在硅胶中加速血管生成的配方。这一配方与最初的肝素“微岛”一起 我们开发的MAP支架将应用于糖尿病小鼠(db/db)夹板伤口愈合模型和 评估伤口闭合、血管生成和新组织形成。如果成功,这个项目将有 工程学和临床意义。该项目将开发第一个地图的计算模型 生物材料支架,并提供关于在计算机实验中如何使生物材料支架 发展。在更大的范围内,这个项目将提供对血管生成反应的更好的理解 我们的新型生物材料,并生产一种廉价而有效的支架治疗选项 加速糖尿病伤口愈合。 这个项目将扩展我的生物材料培训,并为我的技能增加计算建模。这个 弗吉尼亚大学是著名的翻译研究机构,在生物材料和 系统生物学。拟议的研究以及计划的专业发展活动将使 我将成为再生生物材料的独立研究员。
英文摘要
Project Summary In this proposal, we aim to engineer a biomaterial scaffold to accelerate diabetic wound closure by improving upon a new sub-class of hydrogel biomaterials we have invented called Microporous Annealed Particle (MAP) gel. MAP gels are composed of micron-scale spherical building blocks made using microfluidic generation and annealed in situ to form a stable scaffold. MAP scaffolds have shown to improve healing in both skin and brain through porosity dependent reduction in wound inflammation and tissue integration. We are focusing on material improvements to counter a known difficulty for material-based treatment of diabetic wounds; diminished angiogenesis. Specifically, we have developed heparin “micro-islands” to be heterogeneously distributed within the scaffold to form microgradients to promote angiogenesis. We hypothesize optimizing the “heparin micro-island” concentration and spacing will lead to improved angiogenesis and diabetic wound closure. We will evaluate and optimize these properties using both in vivo and in silico approaches. Aim 1 focuses on synthesizing heparin microparticles at various concentrations and quantifying the Vascular Endothelial Growth Factor (VEGF) gradient produced by the particles using a novel assay developed in our lab. The relative gradient strengths will be used to produce an agent-based model of angiogenesis within MAP scaffolds with various concentrations and proportions of heparin islands. Aim 2 focuses on understanding the time-scale of cell distribution and VEGF concentration within a diabetic wound treated with a MAP scaffold. Additionally, using experimental inputs to inform the model, we will run multiple simulations to develop the optimal scaffold formulation to accelerate angiogenesis in silico. This formulation along with the initial heparin “micro-island” MAP scaffold we developed will be applied in a diabetic mouse (db/db) splinted wound healing model and assessed for wound closure, angiogenesis, and new tissue formation. If successful, this project will have engineering and clinical implications. This project will develop the first computational model of a MAP biomaterial scaffold and provide insight on how in silico experiments can inform biomaterial scaffold development. On a greater scale, this project will provide a better understanding of the angiogenic response to our new class of biomaterial and produce an inexpensive and effective scaffold treatment option for accelerating diabetic wound healing. This project will expand upon my biomaterials training and add computational modeling to my skillset. The University of Virginia is a renowned institution for translational research, with strengths in Biomaterials and Systems Biology. The proposed research along with planned professional development activities will enable me to become an independent researcher in regenerative biomaterials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金